We performed a TWAS of bladder cancer risk among individuals of European descent leveraging publicly available genotype and transcriptome data, identifying four genes (SLC39A3, ZNF737, FAM53A, and PPP1R2) with genetically predicted expression levels in whole blood associated with bladder cancer risk. The gene discussed is FAM53A; the disease is urinary bladder cancer.